- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
Day 2 Recap: SBS 2025
Author(s):
Key Takeaways
- Body contouring technologies are evolving, with a focus on non-invasive procedures and market trends in aesthetic medicine.
- Advancements in topical JAK inhibitors, particularly ruxolitinib, show promise in effectiveness, long-term benefits, and pediatric applications.
Catch up on coverage from the second day of the 2025 South Beach Symposium held in Miami Beach, Florida.
To stay informed with the latest conference insights, subscribe to receive our eNewsletters.
The Future of Body Contouring: Insights from David Goldberg, MD, JD
David Goldberg, MD, JD, provided a comprehensive overview of body contouring technologies, emphasizing the evolving landscape of aesthetic medicine and the role of various devices in clinical practice. His discussion centered on selecting the appropriate technology, market trends, and the impact of non-invasive procedures.
What’s Next for Topical JAK Inhibitors?
Matthew Zirwas, MD, a board-certified dermatologist specializing in atopic dermatitis discussed advancements in topical Janus kinase (JAK) inhibitors, particularly ruxolitinib (Opzelura; Incyte), in a recent interview with Dermatology Times. With extensive experience conducting trials on topical JAK inhibitors, Zirwas highlights key aspects of ruxolitinib’s effectiveness, long-term benefits, pediatric applications, and upcoming developments in the field.
Naiem Issa, MD, PhD, FAAD, Discusses Holistic Hair Loss Treatments at SBS 2025
Issa stated, "Medical and interventional therapies don't have to be mutually exclusive. I always look at them as in tandem, because certain people want certain things." He explained that the approach should focus on both stimulating hair growth and maintaining scalp health. According to Issa, every patient’s needs and preferences vary, and treatment plans should be personalized to accommodate those differences. Options range from medical therapies to procedural interventions such as platelet-rich plasma (PRP) therapy, stem cell therapy, and hair transplants.
Nutraceuticals: A Boost for Skin Health
At SBS 2025, Glynis Ablon, MD, a board-certified dermatologist based in Manhattan Beach, California, and an associate clinical professor at UCLA, gave a talk titled, “Nutraceuticals, Supplements, and More.” During the presentation, Ablon emphasized the critical role of nutrition in dermatology and urged clinicians to have these conversations with their patients. Speaking from her experience at the Ablon Skin Institute and Research Center, she highlighted how diet and nutraceuticals can significantly impact skin and hair health.
Chilukuri’s Approach to Safer Aesthetic Treatments
Board-certified dermatologist Suneel Chilukuri, MD, FAAD, FACMS, discussed strategies for preventing complications in minimally invasive dermatological procedures, particularly energy-based devices and injectable treatments. He emphasized the importance of recognizing patients' predisposition to hyperpigmentation and employing pre-treatment protocols to minimize risks.
Exploring Acne Interventions and the Future of Exosomes in Dermatology
Exosomes have emerged as a promising component in the field of regenerative medicine. Michael Gold, MD, introduced exosomes as extracellular vesicles that play crucial roles in cell-to-cell communication. He explained, "Exosomes are part of the world of what we call regenerative medicine, and the exosomes are gaining popularity every day."
